Dime Commercial Bancshares vs Patriot National Bancorp
DCOM and PNBK side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DCOM and PNBK compare
Dime Commercial Bancshares is the larger company, worth 18 times as much as Patriot National Bancorp ($1.8B against $102M).
Patriot National Bancorp grew revenue faster over the last twelve months (81.9% versus 32.9% for Dime Commercial Bancshares).
Dime Commercial Bancshares keeps more of each dollar of sales as profit, with a net margin of 583% compared with −5.5% at Patriot National Bancorp.
Dime Commercial Bancshares pays a dividend yielding 2.4%; Patriot National Bancorp does not pay one.
Dime Commercial Bancshares scores higher on the StockData Score (14 against 6 for Patriot National Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DCOM | PNBK |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $102M |
| Share price | $42.23 | $0.861 |
| Change, 1 year | 58.9% | −24.5% |
| Change, 5 years | 16.5% | −94.3% |
| Beta (5Y) | 0.85 | 0.39 |
| Employees | 902 | 107 |
| StockData Score | ||
| Total score | 14 (better) | 6 |
| Valuation score | 2 | 2 |
| Growth score | 2 (better) | 1 |
| Performance score | 3 (better) | 1 |
| Health score | 4 (better) | 2 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 13.7× | – |
| P/S | 75.4× | 2.1× (better) |
| P/B | 1.2× (better) | 1.2× |
| FCF yield | – | −18.5% |
| Fair value | $39.51 | – |
| Margin of safety | −6.9% | – |
| Growth | ||
| Revenue growth (TTM) | 32.9% | 81.9% (better) |
| Revenue growth, 5Y average | 29.0% | 124% (better) |
| Net income growth (TTM) | 144% | – |
| EPS growth (TTM) | 173% | – |
| EPS growth, 5Y average | 6.3% | – |
| Profitability | ||
| Net margin | 583% (better) | −5.5% |
| FCF margin | – | −38.9% |
| Return on equity | 9.6% (better) | −3.0% |
| Financial health | ||
| Altman Z-score | 0.16 (better) | −0.02 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 2.4% | – |
| Payout ratio | 30.2% | – |
| Buyback yield | – | −9.3% |
| Shareholder yield | 2.4% (better) | −9.3% |
| Ownership | ||
| Held by institutions | 91.3% | 14.6% |
| Held by insiders | 12.3% | 19.6% |
| Insider net buying, 12 months | −$21.9M | $243K (better) |
| Short interest, % of float | – | 1.0% |
Go deeper
- DCOM stock overview
- DCOM income statement
- DCOM valuation and score
- PNBK stock overview
- PNBK income statement
- PNBK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.